您当前的位置:首页病例讨论 >

病例讨论

肝脏显像分析肝脏功能的现状和展望
源自:


参考文献

[1] Philip D. Schneider, MD, PHD. Preoperative assessment of liver function. Surg Clin N Am 84(2004)355-377

[2] 黎一鸣,吕凡,吉鸿,等. 肝脏体积变化与病肝储备功能的关系研究. 中华普通外科杂志, 2003, 18(2):79-81

[3] Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg, 1999, 188(3):304-309

[4] Semelka RC , Helmberger TK. Contrast agents for MR imaging of the liver. Radiology , 2001 , 218 :27

[5] Ryeom HK, Kim SH, Kim JY, et al. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol, 2004, 5(4):231-239[abstract]

[6] Bang N, NielsenMB, Rasmussen AN, et al. Hepatic vein transit time of an ultra sound contrast angent simplified procedure using pulse inversion imaging. Br J Radiol, 2001, 74(884): 752-755

[7] Gasparini C, Bertolotto M, Croce SL, et al. Evaluation of liver parenchymal blood flow with contrast - enhanced US: p reliminary results in healthy and cirrhotic patients. Acad Radiol, 2003, 10 ( 8) : 869 -876.

[8] Kaneko T, Teshigawara O, Sugimoto H, et al. Signal intensity of the liver parenchyma in microbubble contrast agent in the late liver phase reflects advanced fibrosis of the liver. Liver Int, 2005, 25 ( 2) : 288~293.

[9] Talwalker JA, Seaderg E, Kim WR, et al. Predicting clinical and economic outcomes after liver transplantation using the nayo primary sclerosing cholangitis model and Child-Pugh score. Liver Transpl, 2000,6(6):753

[10] 张涛,毛一雷. 肝去唾液酸糖蛋白受体显像:三维分段肝功能评估的前景. 基础医学与临床,2006,26(5):538-541

[11] Mullin EJ, Metcalfe MS, Maddern GJ. How much liver resection is too much[J]? Am J Surg, 2005,190(1):87-97.

[12] Sasaki N, Shiomi S, Iwata Y, et al. Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver. J Nucl Med, 1999 , 40(10):1652-1656

[13] Shuke N, Okizaki A, Kino S, et al. Functional mapping of regional liver asialoglycoprotein receptor amount from single blood sample and SPECT[J].J Nucl Med, 2003,44(3):475-482.

[14] Satoh K, Yamamoto Y, Nishiyama Y, et al. 99mTc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy[J]. Ann Nucl Med, 2003 ,17(1):61-67.

[15] Vera DR, Krohn KA, Stadalnik RC, et al. Tc-99m-galactosyl neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes[J]. Radiology, 1984,151(1):191-196.

[16] 张荣军,梁高林,等. 肝ASGP受体功能显像剂的制备及显像研究. 核技术,2001,23(11):780-785

[17]Sang Kil Ha-Kawa, Yoshimana Tanaka. Quantitative model of Technetium-99m-DTPA-galactoayl-HAS for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med, 1991,32(12):2233

[18] Galli G, Maini CL, Orlando P, et al. A radiopharmeccutical for the study of the liver. 99mTc-DTPA-asialoorosomucoid l. Radiochemical and animal distribution. J Nucl Med Allied Sci, 1988,32(1): 109

[19] Kudo M, Todo A, Ikekubo K, Hino M, Yonekura Y, Yamamoto K, et al. Functional hepatic imaging with receptor-bining radiopharmaceutical: clinical potential as a measure of functioning hepatocyte mass. Gastroenterol Jpn 1991; 26(6): 734-741

[20] Duncan JR and Welch MJ. Intracellular metabolism of indiumlll-DTPA-labeled receptor targeted protein. J Nucl Med 1993,34(10):1728

[21] 李云春,管昌田,等 肝受体显像剂99mTc-DTPA-NGA的研制,华西医大学报,1996,27(1):54-58

[22] Fiume L, Mattioli A, Busi C, et al. Coujugate of adenine 9-A-D-araninofuranoside monophosphate (ara-AMP)with lactosaminated homologous albumin are not immunogenic in the mose. Fxperientia. 1982, 38(9):1087

[23] Shuke N, Okizaki A, Kino S, et al. Functional mapping of regional liver asialoglycoprotein receptor amount from single blood sample and SPECT[J].J Nucl Med, 2003,44(3):475-482.

[24]毛一雷,张涛. 肝硬化患者术前肝功能评估方法的现状和进展,中国医学科学院学报,2006,28(6):849-852

[25]毛一雷,张涛,桑新亭,等 应用单光子发射型计算机断层显像评价剩余肝功能的动物实验研究,中华外科杂志,2007,45(9):

[26]毛一雷,董一女,杨文江,等 肝受体显像剂99mTc-GSA的研制及生物分布(投稿中)